Welcome to European Tribune. It's gone a bit quiet around here these days, but it's still going.
UN WHO calls for global database of human gene editing research
In two reports Monday, WHO's expert group said all studies involving human genome editing should be made public, although the committee noted that wouldn't necessarily stop unprincipled scientists.

"In the field of stem cell research, unscrupulous entrepreneurs and clinics have deliberately misused clinical trial registries by registering procedures they plan to undertake as if they were properly sanctioned clinical trials," the group said, calling for WHO to ensure that all genetic editing research registered in their database are reviewed and approved by an ethics committee.

archived Novartis 2017, He 2018, Sangamo 2019, Moderna 2020
under the radar
China's gene giant harvests data from millions of women, July 2021
Beijing made clear in a 2019 regulation that genetic data can be a national security matter, and since 2015 it has restricted foreign researchers from accessing gene data on Chinese people. In contrast, the United States and Britain give foreign researchers access to genetic data, as part of open science policies.
Wellcome Leap launches $50 million bioengineering initiative, Nov 2020
Established with an initial $300 million investment from Wellcome and modeled on the U.S. Department of Defense's Defense Advanced Research Projects Agency (DARPA), Wellcome Leap funds bold, unconventional projects targeting complex human health challenges.
by Cat on Tue Jul 13th, 2021 at 04:13:05 PM EST
[ Parent ]

Others have rated this comment as follows:


Occasional Series